FeTPPS, a Peroxynitrite Decomposition Catalyst, Ameliorates Nitrosative Stress in Human Spermatozoa.

antioxidant human sperm nitrosative stress peroxynitrite

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
14 Jun 2023
Historique:
received: 12 05 2023
revised: 01 06 2023
accepted: 03 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Excessive levels of reactive nitrogen species (RNS), such as peroxynitrite, promote nitrosative stress, which is an important cause of impaired sperm function. The metalloporphyrin FeTPPS is highly effective in catalyzing the decomposition of peroxynitrite, reducing its toxic effects in vivo and in vitro. FeTPPS has significant therapeutic potential in peroxynitrite-related diseases; however, its effects on human spermatozoa under nitrosative stress have not been described. This work aimed to evaluate the in vitro effect of FeTPPS against peroxynitrite-mediated nitrosative stress in human spermatozoa. For this purpose, spermatozoa from normozoospermic donors were exposed to 3-morpholinosydnonimine, a molecule that generates peroxynitrite. First, the FeTPPS-mediated peroxynitrite decomposition catalysis was analyzed. Then, its individual effect on sperm quality parameters was evaluated. Finally, the effect of FeTPPS on ATP levels, motility, mitochondrial membrane potential, thiol oxidation, viability, and DNA fragmentation was analyzed in spermatozoa under nitrosative stress conditions. The results showed that FeTPPS effectively catalyzes the decomposition of peroxynitrite without affecting sperm viability at concentrations up to 50 μmol/L. Furthermore, FeTPPS mitigates the deleterious effects of nitrosative stress on all sperm parameters analyzed. These results highlight the therapeutic potential of FeTPPS in reducing the negative impact of nitrosative stress in semen samples with high RNS levels.

Identifiants

pubmed: 37372002
pii: antiox12061272
doi: 10.3390/antiox12061272
pmc: PMC10295601
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Alexander von Humboldt Foundation
ID : Research Group Linkage Program (to RS, VI and PM)
Organisme : Universidad de La Frontera, Chile
ID : DI22-3034

Références

Biol Reprod. 2009 Dec;81(6):1106-11
pubmed: 19605785
Free Radic Biol Med. 2010 Nov 15;49(9):1453-67
pubmed: 20708678
Reprod Biomed Online. 2009 Jan;18(1):132-40
pubmed: 19146780
Adv Exp Med Biol. 2019;1166:107-117
pubmed: 31301049
Eur J Pharmacol. 2008 May 31;586(1-3):1-8
pubmed: 18395709
Fertil Steril. 2012 Mar;97(3):554-60
pubmed: 22244784
Chem Res Toxicol. 2012 Aug 20;25(8):1581-97
pubmed: 22775566
J Physiol. 2008 Aug 15;586(16):4011-6
pubmed: 18591189
Andrologia. 2012 Apr;44(2):136-41
pubmed: 21714802
Cytometry A. 2020 Dec;97(12):1238-1247
pubmed: 32530108
Physiol Rev. 2007 Jan;87(1):315-424
pubmed: 17237348
Biol Reprod. 2017 Oct 1;97(4):577-585
pubmed: 29025014
Antioxid Redox Signal. 2014 May 20;20(15):2437-64
pubmed: 23706004
Int J Biol Macromol. 2020 Oct 15;161:336-344
pubmed: 32522548
Nat Rev Drug Discov. 2007 Aug;6(8):662-80
pubmed: 17667957
Asian J Androl. 2018 Nov-Dec;20(6):600-607
pubmed: 29956685
Expert Opin Ther Pat. 2015 Apr;25(4):443-66
pubmed: 25576197
Hum Reprod. 2022 Apr 1;37(4):680-695
pubmed: 35137097
J Neurosci. 2023 Mar 1;43(9):1627-1642
pubmed: 36697259
Biochim Biophys Acta. 2014 Nov;1843(11):2645-61
pubmed: 24983769
Naunyn Schmiedebergs Arch Pharmacol. 2009 Feb;379(2):149-61
pubmed: 18773197
Reprod Domest Anim. 2020 Feb;55(2):229-239
pubmed: 31868975
Hum Reprod. 2002 May;17(5):1257-65
pubmed: 11980749
Andrologia. 2009 Feb;41(1):51-4
pubmed: 19143731
Hum Reprod. 2011 Jul;26(7):1628-40
pubmed: 21546386
Toxicol Appl Pharmacol. 2009 Nov 15;241(1):101-10
pubmed: 19682478
Hum Reprod. 2008 Feb;23(2):259-70
pubmed: 18056059
Mol Hum Reprod. 2015 Mar;21(3):237-43
pubmed: 25425609
Anim Reprod Sci. 2019 Feb;201:71-83
pubmed: 30591234
Antioxidants (Basel). 2021 Jan 12;10(1):
pubmed: 33445539
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):303-9
pubmed: 17138940
Reprod Biol Endocrinol. 2014 Jan 03;12:1
pubmed: 24383664
Fertil Steril. 1985 Oct;44(4):493-8
pubmed: 3902512
Fertil Steril. 2006 Apr;85(4):947-53
pubmed: 16580379
Reproduction. 2013 Oct 01;146(5):R163-74
pubmed: 23901129
Cephalalgia. 2021 Oct;41(11-12):1187-1200
pubmed: 34256650
Andrologia. 1999 Jul;31(4):195-8
pubmed: 10470408
Fertil Steril. 2006 Nov;86(5):1526-30
pubmed: 16996512
Int J Mol Sci. 2022 Sep 12;23(18):
pubmed: 36142487
Curr Mol Med. 2023;23(4):332-340
pubmed: 35400342
Andrologia. 2017 Apr;49(3):
pubmed: 27135897
Circ Res. 2000 Aug 4;87(3):241-7
pubmed: 10926876
J Am Coll Cardiol. 2004 Jun 16;43(12):2348-58
pubmed: 15193704
Syst Biol Reprod Med. 2016 Oct;62(5):325-34
pubmed: 27487446
Andrologia. 2014 Feb;46(1):17-23
pubmed: 23126684
Mol Reprod Dev. 2001 Aug;59(4):451-8
pubmed: 11468782
Int J Androl. 2011 Feb;34(1):2-13
pubmed: 20158539

Auteurs

Pamela Uribe (P)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.
Department of Internal Medicine, Faculty of Medicine, Universidad de La Frontera, Temuco 4781176, Chile.

Javiera Barra (J)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.

Kevin Painen (K)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.

Fabiola Zambrano (F)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.
Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4781176, Chile.

Mabel Schulz (M)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.
Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4781176, Chile.

Claudia Moya (C)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.

Vladimir Isachenko (V)

Research Group in Reproductive Medicine, Department of Obstetrics and Gynecology, Cologne University, 50923 Köln, Germany.

Evgenia Isachenko (E)

Research Group in Reproductive Medicine, Department of Obstetrics and Gynecology, Cologne University, 50923 Köln, Germany.

Peter Mallmann (P)

Research Group in Reproductive Medicine, Department of Obstetrics and Gynecology, Cologne University, 50923 Köln, Germany.

Raúl Sánchez (R)

Center of Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4810296, Chile.
Department of Preclinical Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4781176, Chile.

Classifications MeSH